MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.
2 reports, 2 independent
Updated Sep 23
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat is aggregating consensus ratings for Cytokinetics, while Bank of America provided a neutral rating and Morgan Stanley raised its target price.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cytokinetics
company in South San Francisco, United States
-
MarketBeat
American personal finance blog
-
Morgan Stanley
U.S. investment bank
Related events
- MarketBeat is providing average rating data as Royal Bank of Canada issues a price target report regarding ConocoPhillips.
- MarketBeat provided consensus ratings for MACOM as Susquehanna dropped its price objective and Needham & Company increased its target and gave a buy rating.
- MarketBeat reported MetLife's average rating while Morgan Stanley raised its price target and Bank of America cut its price objective.
- Morgan Stanley and Bank of America raised price targets on NetApp shares, with MarketBeat reporting the consensus rating.
- Global Mofy AI Limited was listed on the stock exchange and received a consensus rating from MarketBeat.